Separately, Numis Securities lifted their price target on Huntsworth from GBX 102 ($1.46) to GBX 109 ($1.56) and gave the stock a buy rating in a research report on Tuesday, March 6th.
LON HNT traded up GBX 1.90 ($0.03) during trading on Wednesday, hitting GBX 96.60 ($1.38). The company’s stock had a trading volume of 401,354 shares, compared to its average volume of 1,010,000. Huntsworth has a 52 week low of GBX 40 ($0.57) and a 52 week high of GBX 95 ($1.36).
The company also recently disclosed a dividend, which will be paid on Thursday, July 5th. Stockholders of record on Thursday, May 24th will be given a dividend of GBX 1.45 ($0.02) per share. The ex-dividend date of this dividend is Thursday, May 24th. This is a boost from Huntsworth’s previous dividend of $0.55. This represents a dividend yield of 1.47%.
In related news, insider Neil Jones purchased 144,590 shares of the firm’s stock in a transaction that occurred on Monday, April 16th. The shares were acquired at an average price of GBX 97 ($1.39) per share, with a total value of £140,252.30 ($200,819.44).
COPYRIGHT VIOLATION NOTICE: This story was first published by The Lincolnian Online and is owned by of The Lincolnian Online. If you are accessing this story on another site, it was copied illegally and reposted in violation of U.S. and international copyright & trademark law. The original version of this story can be viewed at https://www.thelincolnianonline.com/2018/04/18/huntsworth-hnt-stock-rating-reaffirmed-by-peel-hunt-2.html.
Huntsworth Company Profile
Huntsworth plc operates as a healthcare communications and public relations company in the United States, United Kingdom, rest of Europe, Asia, and the Middle East and Africa. It operates through four divisions: Huntsworth Health, Red Consultancy, Grayling, and Citigate Dewe Rogerson (CDR). The Huntsworth Health division offers an integrated suite of communications services for the science, health, and wellbeing industries.
Receive News & Ratings for Huntsworth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Huntsworth and related companies with MarketBeat.com's FREE daily email newsletter.